Children's Health Ireland — Clinical Trial Site

48 Registered trials

29 Currently recruiting

Organisation

Children's Health Ireland

Location

Dublin, Ireland

Identifier

ORG-100022831

Address

Temple Street, D01 YC67, Ireland

Departments

-
#1:Dept of Neurology
#1803: Children's Health Ireland at Temple Street
Cancer Clinical Trials Unit
Cancer Clinical Trials Unit (CCTU)
Cardiology
Children’s Health Ireland
Consultant Haematologist
Department of Neurology
Department of Paediatric Cardiology
Department of Paediatric Neurodisability
Department of Paediatric Oncology
Department of Paediatric Oncology/Haematology
Dermatology
Division of Haematology/Oncology
Gastroenterology
Haematology
Haematology Department
Hematology and Oncology
Metabolic Medicine
NA
Nephrology
Neurology
Oncolgy
Oncology
Paediatric
Paediatric Allergy
Paediatric Cardiology
Paediatric Endocrinology & Diabetes
Paediatric Gastroenterolgy
Paediatric Haematology
Paediatric Haematology Oncology
Pediatric Hematology/Oncology
Pediatrics Allergy
Research & Innovation, Chrildren`s Health Ireland (CHI)
Respiratory department
Respiratory Medicine
The National Centre for Inherited Metabolic Disorders (NCIMD)

Clinical trials at this site (48)

Search interface

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis Subjects 1 Through 11 Years of Age Recruiting

2024-513754-29-00 Cystic Fibrosis 5 2023-03-06
Venetoclax in children with relapsed AML Recruiting

2023-510160-12-00 acute myeloid leukemia 5 2022-08-16
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous Immunotherapy with DBV712 250 µg in 1-thr… Ended

2025-521697-34-00 Peanut allergy 5 2025-12-01
APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participant… Ended

2024-520407-27-00 X-Linked Protoporphyria (XLP) 5 2025-10-23
An open-label study to collect safety and effectiveness information on long-term treatment with vamorolone in boys with Duchenne Muscular Dy… Ended

2024-512828-12-00 Duchenne Muscular Dystrophy 6 2024-12-05
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
A Study of Mavacamten in Adolescent Participants with Symptomatic Obstructive Hypertrophic Cardiomyopathy Ended

2023-505650-17-00 Symptomatic Obstructive Hypertrophic Cardiomyopathy 5 2024-08-27
COACH: A Phase 2, Open-Label, Single-Arm, 156-week Trial to Investigate the Efficacy, Safety and Tolerability of Combined Once Weekly Navepe… Ended

2023-508341-40-00 Children with Achondroplasia 4 2024-07-26
ViaskinTM Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy (VITESSE) Ended

2022-502110-85-00 Peanut allergy 5 2024-01-18
A Study to Examine the Efficacy and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder Ended

2023-506269-78-00 CDKL5 Deficiency disorder 5 2023-06-20
LOGGIC/FIREFLY-2: DAY101 vs. Standard of Care Chemotherapy in Pediatric Patients with Low-Grade Glioma Requiring First-Line Systemic Therapy Ended

2024-510742-13-00 Pediatric low-grade glioma harboring an activating RAF 5 2023-04-19
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Ended

2024-514173-22-00 Cystic Fibrosis 5 2023-02-28
Study of DYNE-251 in Participants with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping Ended

2023-510351-31-00 Duchenne muscular dystrophy 7 2023-01-06
A research study to find out if the study treatment alpelisib (BYL719) is safe for a long period of time for who has confirmed diagnosis of … Ended

2023-508522-95-00 PIK3CA-Related Overgrowth Spectrum (PROS) 4 2022-01-27
Parent and/or Legal Guardian ICF and Adult patient ICF: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study wi… Ended

2022-501012-34-00 Pulmonary Arterial Hypertension 5 2020-02-27
Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction Ended

2023-506210-40-00 Heart Failure due to Systemic Left Ventricular Systolic 5 2024-06-28
An 18-month study to assess joint outcomes in patients with haemophilia A or B on prophylaxis with efmoroctocog alfa or eftrenonacog alfa Ended

2022-502921-16-00 Hemophilia A and B 6 2023-07-21
A phase 2b clinical trial to evaluate efficacy and safety of weekly doses of TransCon CNP compared with placebo in participants with achondr… Ended

2024-515469-32-00 Achondroplasia in Children and Adolescents 4 2023-03-02
A research study of a new investigational medicinal product for the treatment of Duchenne Muscular Dystrophy patients Ended

2024-514698-23-00 Patients with Duchenne Muscular Dystrophy Amenable to E 5 2017-05-15
A study to test the safety and efficacy of the drug larotrectinib for the treatment of tumors with NTRK-fusion in children Ended

2022-502668-20-00 Solid tumors harboring NTRK fusion 9 2017-04-11